MGC Pharmaceuticals Ltd (ASX: MXC) is a European-based specialist Medical Cannabis company built on a mission to be an international pioneer in Phytocannabinoid-based medicine within the biopharmaceutical industry.
Heralding countless years of practical, scientific and business experience, MGC Pharma’s founders are all prominent leaders in the Medical Cannabis industry.
MGC Pharma’s principal business goal is to produce and supply high quality Cannabinoid based pharmaceutical products for the emergent medical markets in Europe, North America and Australasia.
Our founders are all leading figures in the Israeli Medical Cannabis Industry. Their mission is to influence public health around the world by improving the lives of patients with Medical Cannabis.
MGC Pharmaceuticals partners and collaborates with leading companies globally to conduct research and create the highest quality products for our patients.